Balo concentric sclerosis is a rare demyelinating disease. Pathognomonic features have been previously described. Diffusion-wighted imaging findings have not been previously described in Balo concentric sclerosis. We describe the diffusion-weighted imaging findings in a 45-year-old lady with Balo concentric sclerosis. Diffusion-weighted imaging offers insight into the possible pathophysiology of this rare disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1259/bjr/36636301 | DOI Listing |
J Neuroimmunol
January 2025
School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address:
Introduction: Balo concentric sclerosis (BCS) is a rare demyelinating disease. This study aims to follow up on patients initially diagnosed with BCS and MS or presented with BCS in the context of MS.
Methods: This study was conducted at an MS clinic center in Isfahan, monitoring 2600 MS patients, among which 10 cases were related to BCS.
Neurohospitalist
October 2024
Department of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.
The differential diagnosis for multiple intracranial lesions in a young adult is broad and includes demyelinating, neoplastic, and infectious etiologies. In this report, we describe the case of a 19-year-old immunocompetent woman presenting with progressive headaches and aphasia. MRI of the brain revealed multiple, large supratentorial lesions with concentric bands of alternating T2 signal intensities and peripheral contrast enhancement.
View Article and Find Full Text PDFCureus
August 2024
Internal Medicine, Grand Strand Medical Center, Myrtle Beach, USA.
Balo Concentric Sclerosis (BCS) is a rare neurological demyelinating disorder similar to Multiple Sclerosis. Both present with progressive neurological debility but differences on brain imaging help with distinction. The lack of prevalence and general diagnostic information about BCS makes it an underdiagnosed disease which can sometimes delay treatment.
View Article and Find Full Text PDFClin Case Rep
August 2024
Multiple Sclerosis Research Center, Neuroscience Institute Tehran University of Medical Sciences Tehran Iran.
A report of Balo's concentric sclerosis developed alongside with fingolimod use in a patient with previously diagnosed multiple sclerosis.
View Article and Find Full Text PDFHeliyon
June 2024
Department of Neurology, Zhejiang Hospital, Hangzhou, 310013, China.
Introduction: Baló's concentric sclerosis (BCS) is a rare type of central nervous system demyelinating disorder. Most patients with BCS are treated with corticosteroids, and spontaneous remission has seldom been described.
Case Presentation: A 46-year-old man presented with a subacute-onset headache and memory loss.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!